---
schema_version: "secwatch.filing_event.v1"
accession: "0001827090-24-000035"
form_type: "8-K"
ticker: "CERT"
cik: "0001827090"
company_name: "Certara, Inc."
filed_at: "2024-11-06T23:59:59+00:00"
generated_at: "2026-05-30T04:46:30.045933+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Certara Q3 rev $94.8M (+11% YoY); net loss narrows to $1.4M; guides FY24

## Summary
- Revenue $94.8M (+11% YoY); software rev $35.9M (+15%), services rev $58.9M (+9%).
- Net loss $1.4M vs $49.0M loss in Q3 2023; improvement driven by lower goodwill impairment.
- Adjusted EBITDA $33.1M, up 15% from $28.8M in Q3 2023.
- CEO cites Chemaxon acquisition closed; focus on integrating biosimulation platform.
- Full-year 2024 financial guidance updated (specifics not provided in release snippet).

## SEC filing metadata
- accession: 0001827090-24-000035
- form_type: 8-K
- ticker: CERT
- cik: 0001827090
- company_name: Certara, Inc.
- filed_at: 2024-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1827090/000182709024000035/0001827090-24-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1827090/000182709024000035/certara-20241106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001827090-24-000035
- JSON: https://secwatch.observer/filing/0001827090-24-000035.json
- Plain text: https://secwatch.observer/filing/0001827090-24-000035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.